 ENGLEWOOD, Colo., Oct. 13, 2021 PRNewswire -- Zynex, Inc. NASDAQ: ZYXI, an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased Adjusted EBITDA estimate for Q3 2021. 